Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

93 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Value of plasma chitotriosidase to assess non-neuronopathic Gaucher disease severity and progression in the era of enzyme replacement therapy.
van Dussen L, Hendriks EJ, Groener JE, Boot RG, Hollak CE, Aerts JM. van Dussen L, et al. Among authors: groener je. J Inherit Metab Dis. 2014 Nov;37(6):991-1001. doi: 10.1007/s10545-014-9711-x. Epub 2014 May 16. J Inherit Metab Dis. 2014. PMID: 24831585
Gaucher disease due to saposin C deficiency, previously described as non-neuronopathic form--no positive effects after 2-years of miglustat therapy.
Tylki-Szymańska A, Groener JE, Kamiński ML, Ługowska A, Jurkiewicz E, Czartoryska B. Tylki-Szymańska A, et al. Among authors: groener je. Mol Genet Metab. 2011 Dec;104(4):627-30. doi: 10.1016/j.ymgme.2011.09.010. Epub 2011 Sep 16. Mol Genet Metab. 2011. PMID: 21978771
Glycosphingolipids and insulin resistance.
Aerts JM, Boot RG, van Eijk M, Groener J, Bijl N, Lombardo E, Bietrix FM, Dekker N, Groen AK, Ottenhoff R, van Roomen C, Aten J, Serlie M, Langeveld M, Wennekes T, Overkleeft HS. Aerts JM, et al. Among authors: groener j. Adv Exp Med Biol. 2011;721:99-119. doi: 10.1007/978-1-4614-0650-1_7. Adv Exp Med Biol. 2011. PMID: 21910085 Review.
Biomarkers for lysosomal storage disorders: identification and application as exemplified by chitotriosidase in Gaucher disease.
Aerts JM, van Breemen MJ, Bussink AP, Ghauharali K, Sprenger R, Boot RG, Groener JE, Hollak CE, Maas M, Smit S, Hoefsloot HC, Smilde AK, Vissers JP, de Jong S, Speijer D, de Koster CG. Aerts JM, et al. Among authors: groener je. Acta Paediatr. 2008 Apr;97(457):7-14. doi: 10.1111/j.1651-2227.2007.00641.x. Acta Paediatr. 2008. PMID: 18339181 Review.
CCL18: a urinary marker of Gaucher cell burden in Gaucher patients.
Boot RG, Verhoek M, Langeveld M, Renkema GH, Hollak CE, Weening JJ, Donker-Koopman WE, Groener JE, Aerts JM. Boot RG, et al. Among authors: groener je. J Inherit Metab Dis. 2006 Aug;29(4):564-71. doi: 10.1007/s10545-006-0318-8. Epub 2006 May 30. J Inherit Metab Dis. 2006. PMID: 16736095
Monitoring of Gaucher patients with a novel chitotriosidase assay.
Schoonhoven A, Rudensky B, Elstein D, Zimran A, Hollak CE, Groener JE, Aerts JM. Schoonhoven A, et al. Among authors: groener je. Clin Chim Acta. 2007 Jun;381(2):136-9. doi: 10.1016/j.cca.2007.02.042. Epub 2007 Mar 6. Clin Chim Acta. 2007. PMID: 17408605
Elevated globotriaosylsphingosine is a hallmark of Fabry disease.
Aerts JM, Groener JE, Kuiper S, Donker-Koopman WE, Strijland A, Ottenhoff R, van Roomen C, Mirzaian M, Wijburg FA, Linthorst GE, Vedder AC, Rombach SM, Cox-Brinkman J, Somerharju P, Boot RG, Hollak CE, Brady RO, Poorthuis BJ. Aerts JM, et al. Among authors: groener je. Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):2812-7. doi: 10.1073/pnas.0712309105. Epub 2008 Feb 19. Proc Natl Acad Sci U S A. 2008. PMID: 18287059 Free PMC article.
Consequences of a global enzyme shortage of agalsidase beta in adult Dutch Fabry patients.
Smid BE, Rombach SM, Aerts JM, Kuiper S, Mirzaian M, Overkleeft HS, Poorthuis BJ, Hollak CE, Groener JE, Linthorst GE. Smid BE, et al. Among authors: groener je. Orphanet J Rare Dis. 2011 Oct 31;6:69. doi: 10.1186/1750-1172-6-69. Orphanet J Rare Dis. 2011. PMID: 22041095 Free PMC article.
Effects of switching from a reduced dose imiglucerase to velaglucerase in type 1 Gaucher disease: clinical and biochemical outcomes.
van Dussen L, Cox TM, Hendriks EJ, Morris E, Akkerman EM, Maas M, Groener JE, Aerts JM, Deegan PB, Hollak CE. van Dussen L, et al. Among authors: groener je. Haematologica. 2012 Dec;97(12):1850-4. doi: 10.3324/haematol.2011.059071. Epub 2012 Jul 6. Haematologica. 2012. PMID: 22773601 Free PMC article.
Long-term effect of antibodies against infused alpha-galactosidase A in Fabry disease on plasma and urinary (lyso)Gb3 reduction and treatment outcome.
Rombach SM, Aerts JM, Poorthuis BJ, Groener JE, Donker-Koopman W, Hendriks E, Mirzaian M, Kuiper S, Wijburg FA, Hollak CE, Linthorst GE. Rombach SM, et al. Among authors: groener je. PLoS One. 2012;7(10):e47805. doi: 10.1371/journal.pone.0047805. Epub 2012 Oct 19. PLoS One. 2012. PMID: 23094092 Free PMC article.
93 results
Jump to page
Feedback